DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Symbicort Maintenance and Reliever Therapy - Experience in Real Life Setting in Malaysia

Information source: AstraZeneca
Information obtained from ClinicalTrials.gov on November 03, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Asthma

Intervention: Symbicort Turbuhaler 160/4.5 (Drug)

Phase: Phase 4

Status: Recruiting

Sponsored by: AstraZeneca

Official(s) and/or principal investigator(s):
Akhmal Yusof, MD, Study Director, Affiliation: AstraZeneca
Aziah Ahmad Mahayiddin, MD, Principal Investigator, Affiliation: Kuala Lumpur Hospital

Overall contact:
AstraZeneca Sdn Bhd Malaysia Clinical Study, Information, Phone: +603 20892288

Summary

The purpose of the study is to evaluate the satisfaction level of patients using the Symbicort SMART approach for their asthma management.

Clinical Details

Official title: Symbicort Maintenance And Reliever Therapy - Experience in Real Life Setting in Malaysia - SMARTER Study

Study design: Treatment, Non-Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study

Primary outcome: To evaluate the satisfaction level from a patient's perspective using the Symbicort SMART approach by evaluating the changes in Satisfaction of Asthma Treatment Questionnaire (SATQ) scores after 6 months.

Secondary outcome: The evaluate the clinical efficacy of Symbicort SMART approach by evaluating changes in ACQ scores after 6 months of treatment.

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Diagnosis of asthma for past 6 months and treated with inhaled glucocorticosteroids

for at least 3 months.

- Patients who asthma is classified as uncontrolled or partially controlled as defined

by GINA 2006 guidelines.

Exclusion Criteria:

- Patients already on Symbicort SMART treatment.

- Patients who has respiratory tract infection 30 days before study enrolment.

Locations and Contacts

AstraZeneca Sdn Bhd Malaysia Clinical Study, Information, Phone: +603 20892288

Research Site, Kuala Lumpur, Malaysia; Recruiting
Additional Information

Starting date: December 2007
Last updated: February 4, 2008

Page last updated: November 03, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009